Results 91 to 100 of about 1,111,710 (304)

Successful treatment of prosthetic pulmonary valve thrombosis with reteplase: a case report

, 2018
Ramin Khameneh Bagheri1 Faeze Keihanian,2,3 Mostafa Ahmadi,1 Mohammad Ali Ansari2 1Atherosclerosis Prevention Research Center, Imam Reza Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; 2Cardiology Department, Imam ...
Khameneh Bagheri R, Ahmadi M, Ansari MA, Keihanian F   +3 more
core  

Intentional Fracture of Bioprosthetic Valve Frames in Patients Undergoing Valve-in-Valve Transcatheter Pulmonary Valve Replacement.

, 2018
BACKGROUND: Percutaneous transcatheter pulmonary valve replacement (TPVR) has good clinical and hemodynamic outcomes in treating dysfunctional bioprosthetic valves (BPV) in the pulmonary position.
Grohmann, Jochen, Crystal, Matthew A, Balzer, David T, Gillespie, Matthew J, Asnes, Jeremy D, Gillespie, Matthew J., Crystal, Matthew A., Asnes, Jeremy D., Latson, Larry A, Hellenbrand, William, Balzer, David T., Qureshi, Athar M, Berdjis, Farhouch, Rome, Jonathan J, Love, Jon C, Morray, Brian H, McElhinney, Doff B., Gewillig, Marc, Qureshi, Athar M., Tanase, Daniel, Latson, Larry A., Morray, Brian H., Rome, Jonathan J., McElhinney, Doff B, Love, Jon C., Shahanavaz, Shabana, William Hellenbrand, Matthew A. Crystal, Larry A. Latson, Farhouch Berdjis, Jochen Grohmann, Marc Gewillig, Athar M. Qureshi, Shabana Shahanavaz, Matthew J. Gillespie, David T. Balzer, Jeremy D. Asnes, Brian H. Morray, Jonathan J. Rome, Jon C. Love, Doff B. McElhinney, Daniel Tanase   +41 more
core   +1 more source

Implementation and use of risk minimization control tools in the EU: A multistakeholder survey

British Journal of Clinical Pharmacology, EarlyView.
Aims This study characterized stakeholders' experiences with national implementation of risk minimization control tools (RMCTs), such as healthcare professional qualification, healthcare facility accreditation and medical intervention prior to treatment initiation, for eight medicinal products across eight European Union countries. Methods We conducted
Sharon C. M. Essink, Iris R. Joosse, Maximilian Salcher‐Konrad, Melanie Walter, Elena Deligianni, Dimitra Tsioumela, Christos Kontogiorgis, Elita Poplavska, Iluta Žīgure, Christina E. Hoeve, Teresa Leonardo Alves, Ella D. van Vliet, Renato Ferreira‐da‐Silva, Ana Kodrič, Mitja Kos, Juan Erviti, Marta Gutiérrez‐Valencia, Luis Carlos Saiz, Sofia Kälvemark Sporrong, Emelie Karlsson, Christine Leopold, Marie L. De Bruin   +21 more
wiley   +1 more source

Surgical correction of a pulmonary artery aneurysm with severe pulmonary regurgitation with a valve-sparing technique

, 2019
Pulmonary artery aneurysms are rare but are associated with a significant risk of rupture and dissection. Moreover, pulmonary valve regurgitation and/or stenosis often coexist.
Mehta N, Fernandez-Cisneros A, Pereda D, Carino D, Alejandro Fernández-Cisneros, Davide Carino, Daniel Pereda, Nikita Mehta   +7 more
core   +1 more source

Echo-Doppler Features of Pulmonary Valve Endocarditis [PDF]

, 1989
Three patients with fever and pneumonitis were found to have pulmonary valve vegetations by echocardiography. Pulsed and color flow Doppler studies demonstrated mild to moderate pulmonary valve insufficiency in these patients.
Alam, Mohsin, Bitar, Jihad
core   +1 more source

Pneumococcal pulmonary valve endocarditis [PDF]

, 2017
Pulmonary valve endocarditis is a rare type of infective endocarditis (IE). Streptococcus pneumoniae is a pathogen that is uncommonly associated with IE.
Adam Marzetti, Nash, James, Paula Mota, Vrettos, Apostolos, Iain Thorp, Baghai, Max, Max Baghai, James Nash, Thorp, Iain, Mota, Paula, Marzetti, Adam, Apostolos Vrettos   +11 more
core   +1 more source

CYP3A5 genetic variability influences sildenafil and metabolite in pulmonary hypertension

British Journal of Clinical Pharmacology, EarlyView.
Aim Interindividual variability in sildenafil response among pulmonary hypertension patients (PH) may be influenced by CYP3A5 polymorphisms. CYP3A5*3 allele reduces CYP3A5 activity and affects sildenafil metabolism. This study investigated the associations between CYP3A5 genotype and plasma concentrations of sildenafil and N‐desmethyl sildenafil, as ...
Pranisa Wongwien, Burabha Pussadhamma, Sirimas Kanjanawart, Thikhumporn Areesinpitak, Nontaya Nakkam, Chingching Foocharoen, Wichittra Tassaneeyakul, Suda Vannaprasaht   +7 more
wiley   +1 more source

Pulmonary valve stenosis

, 2018
Pulmonary valve stenosis may present at different ages and most patients can be treated by interventional catheter. The outlook is excellent, provided there are no associated abnormalities.
Robert Yates
core   +1 more source

Interdisciplinary three-step strategy to treat aortic stenosis and coronary artery disease in a patient with end-stage chronic obstructive pulmonary disease [PDF]

, 2012
Background: Valvular aortic stenosis is a common disease in the elderly, often in multimorbid patients. It is often associated with coronary artery disease and peripheral artery disease.
Michel, Sebastian, Schmitz, Christoph, Kaczmarek, Ingo, Sodian, Ralf, Wolf, Manuel, Bigdeli, Amir Khosrow, Beiras Fernández, Andrés   +6 more
core   +1 more source

Comparative treatment effects of direct oral anticoagulants versus warfarin for nonvalvular atrial fibrillation in clinical practice vary over time due to channelling

British Journal of Clinical Pharmacology, EarlyView.
Aim Temporal shifts in patient characteristics can influence comparative treatment effects within a certain indication. We investigated patient characteristics and comparative effectiveness and safety for direct oral anticoagulants (DOACs) and warfarin over the time period where DOACs replaced warfarin as preferred stroke prophylaxis in patients with ...
Raoul B. L. J. van den Hemel, Aernoud T. L. Fiolet, Magdalena A. Gamba, Patrick C. Souverein, Olaf H. Klungel, Lourens T. Bloem, Sophie H. Bots   +6 more
wiley   +1 more source